Safety evaluation of excessive consumption of the test food: an open-label trial - Safety evaluation of excessive consumption of the test food

ORTHOMEDICO Inc.0 个研究点目标入组 22 人开始时间: 2020年11月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, irritable bowel syndrome (IBS), or any other chronic diseases 4. Subjects regularly taking medications (including herbal medicines) and supplements 5. Subjects allergic to medications and/or soybeans 6. Subjects who are pregnant, lactating, or intending to become pregnant 7. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 8. Subjects who are judged as ineligible to participate in the study by the physician

发起方